Tharimmune Inc. (THAR)
NASDAQ: THAR
· Real-Time Price · USD
1.78
0.61 (52.14%)
At close: Aug 20, 2025, 9:42 AM
52.14% (1D)
| Bid | 1.87 |
| Market Cap | 8.23M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.48M |
| EPS (ttm) | -6.06 |
| PE Ratio (ttm) | -0.29 |
| Forward PE | -1.65 |
| Analyst | Buy |
| Ask | 1.88 |
| Volume | 40,830,375 |
| Avg. Volume (20D) | 66,750 |
| Open | 1.42 |
| Previous Close | 1.17 |
| Day's Range | 1.34 - 1.78 |
| 52-Week Range | 0.95 - 6.39 |
| Beta | 1.19 |
About THAR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol THAR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for THAR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 hour ago
Tharimmune shares are trading higher after the com...
Unlock content with
Pro Subscription
6 days ago
-5.71%
THAR stock has given up its prior gain. Tharimmune shares were trading higher after the company announced recent TH-104 patents in several countries.
